Charitable Pharmacies of America organization member receives Health Equity grant
Related Posts
Today’s release of new 2020 Census data provides population counts of nearly 1,500 race and ethnicity groups and American Indian and Alaska Native (AIAN) tribes and villages.
This study represents a rigorous, multi-state evaluation that highlights the impact of a charitable medication access program on hospital utilization for the medically under-served population.
An opportunity for charitable pharmacies to collaborate with oncology practices for non-oncology medications during and after treatment.
Three Healthcare Organizations Join Forces to Save Lives
Good Pill will provide direct access to hundreds of life-saving medications and save families $150+/month on healthcare cost
Medication non-adherence has led to at least 100,000 preventable deaths each year and $100 billion annually in preventable healthcare costs in the United States
An opportunity for charitable pharmacies to collaborate with oncology practices for non-oncology medications during and after treatment.
Charitable Pharmacies of America organization member receives Health Equity grant
Just as banks have helped seniors bridge the digital divide and leverage online banking to better manage their money, healthcare organizations need to help older adults leverage digital technology to better manage their health.
The Outcomes of Implementing and Integrating Comprehensive Medication Management in Team-Based Care: A Review of the Evidence on Quality, Access and Costs, December 2023
FDA approves 1 Year delay of Track & Trace requirements
A Fireside Chat with AAM Chair, Christine Baeder and Mark Cuban, Entrepreneur and Cost Plus founder
In 2011, the opioid crisis reached astounding levels with over 21,000 deaths adding to the urgency of providing aid to those who most need it
Implications for Patients
Once the continuous enrollment ends, it is estimated between 5 -14 million individuals will be affected
Significant improvement in glycemic control among participants demonstrates the substantial impact that pharmacies partnered with charitable medication distributors such as the Dispensary of Hope can have on individuals with insulin-treated T2D

